Clinical Trial Update: A Multiple Dose Trial Evaluating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PF-04457845 in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 multiple-dose trial in healthy volunteers assessing safety, tolerability, pharmacokinetics and pharmacodynamics of PF-04457845; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain

Drugs mentioned

• PF-04457845

Snippet

Sponsor: Pfizer | Conditions: Acute Pain, Chronic Pain | Phase 1 | Status: COMPLETED